JP2009508476A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009508476A5 JP2009508476A5 JP2008529350A JP2008529350A JP2009508476A5 JP 2009508476 A5 JP2009508476 A5 JP 2009508476A5 JP 2008529350 A JP2008529350 A JP 2008529350A JP 2008529350 A JP2008529350 A JP 2008529350A JP 2009508476 A5 JP2009508476 A5 JP 2009508476A5
- Authority
- JP
- Japan
- Prior art keywords
- cell line
- antibody
- polypeptide
- produced
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71305505P | 2005-08-31 | 2005-08-31 | |
| US71285805P | 2005-08-31 | 2005-08-31 | |
| PCT/US2006/034382 WO2007028106A2 (en) | 2005-08-31 | 2006-08-31 | Host cell lines for production of antibody constant region with enhanced effector function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009508476A JP2009508476A (ja) | 2009-03-05 |
| JP2009508476A5 true JP2009508476A5 (enExample) | 2009-09-24 |
Family
ID=37809622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529350A Pending JP2009508476A (ja) | 2005-08-31 | 2006-08-31 | 高められたエフェクター機能をもつ抗体定常領域の製造用の宿主細胞株 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090214528A1 (enExample) |
| EP (1) | EP1937313A4 (enExample) |
| JP (1) | JP2009508476A (enExample) |
| KR (1) | KR20080048505A (enExample) |
| AU (1) | AU2006287224A1 (enExample) |
| BR (1) | BRPI0616600A2 (enExample) |
| CA (1) | CA2621236A1 (enExample) |
| MX (1) | MX2008003054A (enExample) |
| WO (1) | WO2007028106A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275540B1 (en) | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| FR2807767B1 (fr) * | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| EP2434894B1 (en) * | 2009-05-29 | 2016-08-31 | Novartis AG | Methods of administration of thrombopoietin agonist compounds |
| EP4328305A3 (en) * | 2009-12-18 | 2024-08-14 | CSL Ltd. | Method of purifying polypeptides |
| GB201003701D0 (en) * | 2010-03-05 | 2010-04-21 | Cilian Ag | System for the expression of a protein |
| WO2013087914A1 (en) | 2011-12-16 | 2013-06-20 | Synthon Biopharmaceuticals B.V. | EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| BR112015013105B1 (pt) | 2012-12-05 | 2022-02-08 | Alnylam Pharmaceuticals, Inc | Agente de rnai de fita dupla capaz de inibir a expressão de pcsk9, seus usos, composição farmacêutica e método de inibição da expressão de pcsk9 em uma célula in vitro |
| US9677105B2 (en) | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US8956830B2 (en) * | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| KR20170010003A (ko) * | 2014-05-27 | 2017-01-25 | 아카데미아 시니카 | 박테로이드 기원의 푸코시다제 및 이의 사용 방법 |
| EP3340994A1 (en) * | 2015-08-25 | 2018-07-04 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for treating a proprotein convertase subtilisin kexin (pcsk9) gene-associated disorder |
| US10465003B2 (en) * | 2016-02-05 | 2019-11-05 | Janssen Biotech, Inc. | Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes |
| CN110234351A (zh) * | 2017-01-30 | 2019-09-13 | 詹森生物科技公司 | 用于治疗活动性银屑病关节炎的抗tnf抗体、组合物和方法 |
| KR20240038148A (ko) * | 2017-02-07 | 2024-03-22 | 얀센 바이오테크 인코포레이티드 | 활성 강직성 척추염의 치료를 위한 항-tnf 항체, 조성물, 및 방법 |
| KR102323342B1 (ko) | 2019-04-26 | 2021-11-08 | 주식회사 와이바이오로직스 | IL-17A 및 TNF-α에 특이적으로 결합하는 이중표적 항체 |
| AU2020267953A1 (en) * | 2019-05-08 | 2021-11-18 | Novartis Ag | Anti-CD40 antibodies for use in treatment of T1DM and insulitis |
| EP3972690A4 (en) * | 2019-05-23 | 2023-07-05 | Janssen Biotech, Inc. | METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE USING COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF-ALPHA |
| CA3183927A1 (en) | 2020-05-21 | 2021-11-25 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1079704A (en) | 1912-06-19 | 1913-11-25 | Dallas C Hathaway | Combination tire valve-stem and pressure-gage. |
| DE3167442D1 (en) | 1980-07-07 | 1985-01-10 | Nat Res Dev | Improvements in or relating to cell lines |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4816597A (en) * | 1983-10-02 | 1989-03-28 | New Jersey Institute Of Technology | Dental restorative materials based upon blocked isocyanates |
| GB8421551D0 (en) | 1984-08-24 | 1984-09-26 | Ici Plc | Water-soluble dye |
| EP0833911B1 (en) | 1995-06-07 | 2004-05-12 | Ortho Pharmaceutical Corporation | Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| AU736993B2 (en) * | 1997-01-16 | 2001-08-09 | Novo Nordisk A/S | Practical in vitro sialylation of recombinant glycoproteins |
| JP4334141B2 (ja) | 1998-04-20 | 2009-09-30 | グリカート バイオテクノロジー アクチェンゲゼルシャフト | 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作 |
| EP2275540B1 (en) * | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| DE60230858D1 (de) | 2001-02-15 | 2009-03-05 | Centocor Inc | Chemisch definiertes medium für kultivierte säugerzellen |
| EP1498490A4 (en) * | 2002-04-09 | 2006-11-29 | Kyowa Hakko Kogyo Kk | PROCESS FOR PREPARING ANTIBODY COMPOSITION |
| WO2003084570A1 (en) | 2002-04-09 | 2003-10-16 | Kyowa Hakko Kogyo Co., Ltd. | DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM |
| KR20050000380A (ko) * | 2002-04-09 | 2005-01-03 | 교와 핫꼬 고교 가부시끼가이샤 | 게놈이 개변된 세포 |
| US7605235B2 (en) * | 2003-05-30 | 2009-10-20 | Centocor, Inc. | Anti-tissue factor antibodies and compositions |
| JP2006526641A (ja) * | 2003-05-30 | 2006-11-24 | セントカー・インコーポレーテツド | 抗−組織因子抗体を用いる腫瘍成長を抑制する方法 |
-
2006
- 2006-08-31 AU AU2006287224A patent/AU2006287224A1/en not_active Abandoned
- 2006-08-31 US US12/065,178 patent/US20090214528A1/en not_active Abandoned
- 2006-08-31 MX MX2008003054A patent/MX2008003054A/es not_active Application Discontinuation
- 2006-08-31 WO PCT/US2006/034382 patent/WO2007028106A2/en not_active Ceased
- 2006-08-31 JP JP2008529350A patent/JP2009508476A/ja active Pending
- 2006-08-31 KR KR1020087007406A patent/KR20080048505A/ko not_active Ceased
- 2006-08-31 CA CA002621236A patent/CA2621236A1/en not_active Abandoned
- 2006-08-31 BR BRPI0616600-8A patent/BRPI0616600A2/pt not_active Application Discontinuation
- 2006-08-31 EP EP06814116A patent/EP1937313A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12084496B2 (en) | Anti-ROR antibody constructs | |
| TWI586686B (zh) | 胰高血糖素受體之人類抗體 | |
| EP3561058B1 (en) | Fusion protein including bdnf | |
| BR112020026862A2 (pt) | antagonistas antitumorais de reguladores de pontos de verificação imunológica | |
| CN107217042A (zh) | 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法 | |
| JP2008537874A5 (enExample) | ||
| CN111601821B (zh) | 具有对FcRn的亲和力提高以及对至少一个Fc片段受体的亲和力提高的Fc片段的变体 | |
| TW200415241A (en) | Fc fusion proteins of human erythropoietin with high biological activities | |
| JP2008515446A5 (enExample) | ||
| AU2016341409B2 (en) | Single-chain CD27-receptor agonist proteins | |
| CA2663042A1 (en) | Serum albumin binding proteins with long half-lives | |
| TW201348247A (zh) | 利用蛋白質ａ親和性層析之非人類抗體之新穎純化 | |
| AU2019327493A1 (en) | Combination therapies comprising sirp alpha-based chimeric proteins | |
| CA3002588C (en) | Single-chain cd137-receptor agonist proteins | |
| JP2014530001A5 (enExample) | ||
| CN106232135B (zh) | Uti融合蛋白 | |
| JPH01502669A (ja) | 精製された血小板由来の成長因子及びその精製方法 | |
| WO2015172305A1 (zh) | 抑制taci-baff复合物形成的融合蛋白及其制法和用途 | |
| CN105820248A (zh) | 一种新型抗egfr单克隆抗体的制备方法及应用 | |
| JP2018533948A (ja) | 一本鎖ｌｉｇｈｔ受容体アゴニストタンパク質 | |
| TW201945392A (zh) | Gcgr抗體及其與glp-1的融合蛋白質，以及其藥物組合物和應用 | |
| JP2010512306A5 (enExample) | ||
| CN119907811A (zh) | 针对cd28的多功能分子 | |
| CA3003511A1 (en) | Single-chain tl1a receptor agonist proteins | |
| WO2022143516A1 (zh) | 一种人glp-1多肽变体及其应用 |